European Medical Solutions (STU:AS00) Net Margin %: 3.22% (As of Dec. 2025)


STU:AS00 European Medical Solutions STU:AS00
45 GF Score
Price €4.74
GF Value €8.10
! 2 Warning Signs
View Full Analysis

What is European Medical Solutions Net Margin %?

European Medical Solutions STU:AS00 +0.42% 45 Net Margin % is 3.22% as of Dec. 2025. GuruFocus rates STU:AS00 with a GF Score™ of 45/100 and a GF Value™ of €8.10. The stock has 2 warning signs investors should review. Among 947 Biotechnology companies, European Medical Solutions ranks better than 74.23% on this metric.

Net margin is calculated as Net Income divided by its Revenue. European Medical Solutions's Net Income for the six months ended in Dec. 2025 was €0.85 Mil. European Medical Solutions's Revenue for the six months ended in Dec. 2025 was €26.41 Mil. Therefore, European Medical Solutions's net margin for the quarter that ended in Dec. 2025 was 3.22%.

The historical rank and industry rank for European Medical Solutions's Net Margin % or its related term are showing as below:

STU:AS00' s Net Margin % Range Over the Past 10 Years
Min: -15.81   Med: -0.66   Max: 3.69
Current: 3.69

STU:AS00's Net Margin % is ranked better than
74.23% of 947 companies
in the Biotechnology industry
Industry Median: -89.33 vs STU:AS00: 3.69

European Medical Solutions  (STU:AS00) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

European Medical Solutions Net Margin % Related Terms

European Medical Solutions Net Margin % Historical Data

* Premium members only.

The historical data trend for European Medical Solutions's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

European Medical Solutions Net Margin % Chart

European Medical Solutions Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.66 -15.81 -1.75 1.21 3.69

European Medical Solutions Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.26 1.66 0.79 4.21 3.22

STU:AS00 vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, European Medical Solutions's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

European Medical Solutions Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, European Medical Solutions's Net Margin % distribution charts can be found below:

* The bar in red indicates where European Medical Solutions's Net Margin % falls into.


STU:AS00
45GF Score
European Medical Solutions STU:AS00
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

European Medical Solutions Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

European Medical Solutions's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=1.84/49.922
=3.69 %

European Medical Solutions's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0.851/26.405
=3.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 3.22% mean?
European Medical Solutions (STU:AS00) has a Net Margin % of 3.22% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on European Medical Solutions and its competitors. According to the industry distribution chart, European Medical Solutions ranks #244 out of 947 companies in the Biotechnology industry, placing it in the top 25.8%.
Is European Medical Solutions' Net Margin % too high?
European Medical Solutions' current Net Margin % is 3.22%. Based on the distribution chart, European Medical Solutions ranks #244 out of 947 companies in the Biotechnology industry, which is above the industry midpoint. Overall, European Medical Solutions has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does European Medical Solutions' Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, European Medical Solutions ranks #244 out of 947 companies for Net Margin %. This puts European Medical Solutions in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on European Medical Solutions and its competitors. European Medical Solutions's current Net Margin % is 3.22%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is European Medical Solutions stock overvalued right now?
European Medical Solutions (STU:AS00) has a current Net Margin % of 3.22%. The stock's GF Value™ is €8.10, compared to a current price of €4.74 — trading 41.5% below its estimated fair value. The current Net Margin % is 3.22%. European Medical Solutions' overall GF Score™ is 45/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For European Medical Solutions (STU:AS00), the current Net Margin % is 3.22% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is European Medical Solutions (STU:AS00) Overvalued in 2026?

Based on GuruFocus' analysis, European Medical Solutions stock appears to be undervalued. The current stock price of €4.74 is trading 41.5% below its estimated GF Value™ of €8.10.

Key valuation signals for STU:AS00:

  • Net Margin %: 3.22%
  • GF Value™: €8.10 vs. price of €4.74 (41.5% below fair value)
  • GF Score™: 45/100 with 2 warning signs

No single metric tells the full story. See the STU:AS00 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

European Medical Solutions Business Description

Other Exchanges ALEMS:Belgium
Address 7 Rue des Chasseurs Ardennais, Liege, BEL, 4031
European Medical Solutions Formerly DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.
45GF Score

Get the complete analysis for STU:AS00

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.74
Price
€8.10
GF Value